Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Venous thromboembolism in patients with primary bone or soft-tissue sarcomas.

Mitchell SY, Lingard EA, Kesteven P, McCaskie AW, Gerrand CH.

J Bone Joint Surg Am. 2007 Nov;89(11):2433-9.

PMID:
17974886
2.

Incidence of symptomatic venous thromboembolism after elective knee arthroscopy.

Maletis GB, Inacio MC, Reynolds S, Funahashi TT.

J Bone Joint Surg Am. 2012 Apr 18;94(8):714-20. doi: 10.2106/JBJS.J.01759.

PMID:
22517387
3.

Risk factors for post-operative venous thromboembolism in patients with a malignancy of the lower limb.

Kim SM, Park JM, Shin SH, Seo SW.

Bone Joint J. 2013 Apr;95-B(4):558-62. doi: 10.1302/0301-620X.95B4.30416.

PMID:
23539711
4.

Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.

Dorr LD, Gendelman V, Maheshwari AV, Boutary M, Wan Z, Long WT.

J Bone Joint Surg Am. 2007 Dec;89(12):2648-57.

PMID:
18056497
5.

Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis.

Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP.

J Bone Joint Surg Am. 2010 Sep 15;92(12):2156-64. doi: 10.2106/JBJS.I.00882.

PMID:
20844157
6.

The incidence of thromboembolic events in surgically treated ankle fracture.

Pelet S, Roger ME, Belzile EL, Bouchard M.

J Bone Joint Surg Am. 2012 Mar 21;94(6):502-6. doi: 10.2106/JBJS.J.01190.

PMID:
22437998
7.

Incidence of symptomatic venous thromboembolism in oncologic patients undergoing lower-extremity endoprosthetic arthroplasty.

Ramo BA, Griffin AM, Gill CS, McDonald DJ, Wunder JS, Ferguson P, Bell RS, Phillips SE, Schwartz HS, Holt GE.

J Bone Joint Surg Am. 2011 May 4;93(9):847-54. doi: 10.2106/JBJS.H.01640.

PMID:
21543674
8.

The role of clinically significant venous thromboembolism and thromboprophylaxis in pediatric patients with pelvic or femoral fractures.

Greenwald LJ, Yost MT, Sponseller PD, Abdullah F, Ziegfeld SM, Ain MC.

J Pediatr Orthop. 2012 Jun;32(4):357-61. doi: 10.1097/BPO.0b013e31824b2a07.

PMID:
22584835
9.

Incidence and risk factors of venous thromboembolic events in lymphoma.

Zhou X, Teegala S, Huen A, Ji Y, Fayad L, Hagemeister FB, Gladish G, Vadhan-Raj S.

Am J Med. 2010 Oct;123(10):935-41. doi: 10.1016/j.amjmed.2010.05.021.

PMID:
20920696
10.

Symptomatic venous thromboembolism uncommon without thromboprophylaxis after isolated lower-limb fracture: the knee-to-ankle fracture (KAF) cohort study.

Selby R, Geerts WH, Kreder HJ, Crowther MA, Kaus L, Sealey F.

J Bone Joint Surg Am. 2014 May 21;96(10):e83. doi: 10.2106/JBJS.M.00236.

PMID:
24875035
11.

The prevalence of and specific risk factors for venous thromboembolic disease following elective spine surgery.

Sansone JM, del Rio AM, Anderson PA.

J Bone Joint Surg Am. 2010 Feb;92(2):304-13. doi: 10.2106/JBJS.H.01815.

PMID:
20124056
12.

Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.

Colwell CW Jr, Collis DK, Paulson R, McCutchen JW, Bigler GT, Lutz S, Hardwick ME.

J Bone Joint Surg Am. 1999 Jul;81(7):932-40.

PMID:
10428124
13.

Older soft tissue sarcoma patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data.

Shantakumar S, Connelly-Frost A, Kobayashi MG, Allis R, Li L.

Clin Sarcoma Res. 2015 Jul 26;5:18. doi: 10.1186/s13569-015-0033-z. eCollection 2015.

14.

Clinically significant venous thromboembolic complications in burn patients receiving unfractionated heparin or enoxaparin as prophylaxis.

Bushwitz J, LeClaire A, He J, Mozingo D.

J Burn Care Res. 2011 Nov-Dec;32(6):578-82. doi: 10.1097/BCR.0b013e31822dc3c7.

PMID:
21841495
15.

Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.

Khaldi A, Helo N, Schneck MJ, Origitano TC.

J Neurosurg. 2011 Jan;114(1):40-6. doi: 10.3171/2010.8.JNS10332. Epub 2010 Sep 3.

PMID:
20815694
16.

A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.

Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH.

J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38.

PMID:
10901307
17.

Venous thromboembolism in the Chinese population--experience in a regional hospital in Hong Kong.

Liu HS, Kho BC, Chan JC, Cheung FM, Lau KY, Choi FP, Wu WC, Yau TK.

Hong Kong Med J. 2002 Dec;8(6):400-5.

18.

Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.

Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL.

Anesthesiology. 2003 Sep;99(3):552-60; discussion 5A.

PMID:
12960538
19.

[Venous thromboembolism prophylaxis after total hip arthroplasty].

Kučera T, Malý R, Urban K, Sponer P.

Acta Chir Orthop Traumatol Cech. 2011;78(2):101-5. Czech.

PMID:
21575551
20.

IVC filters may prevent fatal pulmonary embolism in musculoskeletal tumor surgery.

Tuy B, Bhate C, Beebe K, Patterson F, Benevenia J.

Clin Orthop Relat Res. 2009 Jan;467(1):239-45. doi: 10.1007/s11999-008-0607-7. Epub 2008 Nov 7.

Supplemental Content

Support Center